Literature DB >> 26052777

Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis.

Katherine J Hahn1, Nancy Ho2, Lynne Yockey3, Samantha Kreuzberg2, Janine Daub3, Amy Rump3, Beatriz E Marciano3, Martha Quezado4, Harry L Malech5, Steven M Holland3, Theo Heller2, Christa S Zerbe3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26052777     DOI： 10.1038/ajg.2015.135

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  7 in total

1.  Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients.

Authors:  Meghna Alimchandani; Jin-Ping Lai; Phyu Phyu Aung; Sajneet Khangura; Natasha Kamal; John I Gallin; Steven M Holland; Harry L Malech; Theo Heller; Markku Miettinen; Martha M Quezado
Journal:  Am J Surg Pathol       Date:  2013-09       Impact factor: 6.394

2.  Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis.

Authors:  Gulbu Uzel; Jordan S Orange; Nina Poliak; Beatriz E Marciano; Theo Heller; Steven M Holland
Journal:  Clin Infect Dis       Date:  2010-11-08       Impact factor: 9.079

3.  A simple index of Crohn's-disease activity.

Authors:  R F Harvey; J M Bradshaw
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

4.  Residual NADPH oxidase and survival in chronic granulomatous disease.

Authors:  Douglas B Kuhns; W Gregory Alvord; Theo Heller; Jordan J Feld; Kristen M Pike; Beatriz E Marciano; Gulbu Uzel; Suk See DeRavin; Debra A Long Priel; Benjamin P Soule; Kol A Zarember; Harry L Malech; Steven M Holland; John I Gallin
Journal:  N Engl J Med       Date:  2010-12-30       Impact factor: 91.245

5.  Chronic granulomatous disease. Report on a national registry of 368 patients.

Authors:  J A Winkelstein; M C Marino; R B Johnston; J Boyle; J Curnutte; J I Gallin; H L Malech; S M Holland; H Ochs; P Quie; R H Buckley; C B Foster; S J Chanock; H Dickler
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

6.  Gastrointestinal involvement in chronic granulomatous disease.

Authors:  Beatriz E Marciano; Sergio D Rosenzweig; David E Kleiner; Victoria L Anderson; Dirk N Darnell; Sandra Anaya-O'Brien; Dianne M Hilligoss; Harry L Malech; John I Gallin; Steven M Holland
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

7.  IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.

Authors:  Antonella de Luca; Sanne P Smeekens; Andrea Casagrande; Rossana Iannitti; Kara L Conway; Mark S Gresnigt; Jakob Begun; Theo S Plantinga; Leo A B Joosten; Jos W M van der Meer; Georgios Chamilos; Mihai G Netea; Ramnik J Xavier; Charles A Dinarello; Luigina Romani; Frank L van de Veerdonk
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205
  7 in total
  17 in total

Review 1.  The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies.

Authors:  Dror S Shouval; Matthew Kowalik; Scott B Snapper
Journal:  J Clin Immunol       Date:  2018-06-29       Impact factor: 8.317

Review 2.  Inflammatory consequences of inherited disorders affecting neutrophil function.

Authors:  Mary C Dinauer
Journal:  Blood       Date:  2019-03-21       Impact factor: 22.113

Review 3.  Chronic granulomatous disease.

Authors:  Dirk Roos
Journal:  Br Med Bull       Date:  2016-03-16       Impact factor: 4.291

Review 4.  Primary immune deficiencies with defects in neutrophil function.

Authors:  Mary C Dinauer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 5.  Linking Genetic Diagnosis to Therapeutic Approach in Very Early Onset Inflammatory Bowel Disease: Pharmacologic Considerations.

Authors:  Anne E Levine; Hengqi B Zheng; David L Suskind
Journal:  Paediatr Drugs       Date:  2022-04-25       Impact factor: 3.022

6.  Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.

Authors:  Rebecca A Marsh; Jennifer W Leiding; Brent R Logan; Linda M Griffith; Danielle E Arnold; Elie Haddad; E Liana Falcone; Ziyan Yin; Kadam Patel; Erin Arbuckle; Jack J Bleesing; Kathleen E Sullivan; Jennifer Heimall; Lauri M Burroughs; Suzanne Skoda-Smith; Shanmuganathan Chandrakasan; Lolie C Yu; Benjamin R Oshrine; Geoffrey D E Cuvelier; Monica S Thakar; Karin Chen; Pierre Teira; Shalini Shenoy; Rachel Phelan; Lisa R Forbes; Deepak Chellapandian; Blachy J Dávila Saldaña; Ami J Shah; Katja G Weinacht; Avni Joshi; Farid Boulad; Troy C Quigg; Christopher C Dvorak; Debi Grossman; Troy Torgerson; Pamela Graham; Vinod Prasad; Alan Knutsen; Hey Chong; Holly Miller; M Teresa de la Morena; Kenneth DeSantes; Morton J Cowan; Luigi D Notarangelo; Donald B Kohn; Elizabeth Stenger; Sung-Yun Pai; John M Routes; Jennifer M Puck; Neena Kapoor; Michael A Pulsipher; Harry L Malech; Suhag Parikh; Elizabeth M Kang
Journal:  J Clin Immunol       Date:  2019-08-02       Impact factor: 8.317

Review 7.  Future of Care for Patients With Chronic Granulomatous Disease: Gene Therapy and Targeted Molecular Medicine.

Authors:  Michael D Keller; Luigi D Notarangelo; Harry L Malech
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164

8.  Neutrophil-Derived Tumor Necrosis Factor Drives Fungal Acute Lung Injury in Chronic Granulomatous Disease.

Authors:  R Elaine Cagnina; Kathryn R Michels; Alexandra M Bettina; Marie D Burdick; Yogesh Scindia; Zhimin Zhang; Thomas J Braciale; Borna Mehrad
Journal:  J Infect Dis       Date:  2021-10-13       Impact factor: 5.226

Review 9.  Chronic Granulomatous Disease: a Comprehensive Review.

Authors:  Hsin-Hui Yu; Yao-Hsu Yang; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2021-10       Impact factor: 8.667

10.  Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease.

Authors:  Alessandra Magnani; Nizar Mahlaoui
Journal:  Paediatr Drugs       Date:  2016-10       Impact factor: 3.930
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.